Popa S. New approaches in modulating the GLP-1/GLP-2 AXIS: link between metabolic diseases and inflammatory bowel disease. RJDNMD [Internet]. 30Sep.2022 [cited 15Jun.2026];29(3):376-80. Available from: https://www.rjdnmd.org/index.php/RJDNMD/article/view/1181